Since antibodies for the African Swine Fever virus have been detected in humans, the possibility of human infection with the African Swine Fever virus exists and may thus far have escaped any systematic screening. Thus, any preventive and therapeutic approach to African Swine Fever can have far-reaching implications to control immune deficiency conditions in humans.

Polypeptides from African Swine Fever virus as vaccines for preventive and therapeutic use

https://patents.google.com/patent/US20080131449